Supplement

You have full text access to this OnlineOpen article

Total burden and incidence of in situ and invasive cervical carcinoma in Michigan, 1985–2003†‡

  1. Glenn Copeland MBA1,§,*,
  2. S. Deblina Datta MD2,
  3. Georgia Spivak BS1,
  4. Ann Davis Garvin MS, CNM3,
  5. Michele L. Cote PhD4

Article first published online: 3 NOV 2008

DOI: 10.1002/cncr.23747

Issue

Cancer

Cancer

Supplement: Assessing the Burden of HPV-Associated Cancers in the United States

Volume 113, Issue Supplement 10, pages 2946–2954, 15 November 2008

Additional Information

How to Cite

Copeland, G., Datta, S. D., Spivak, G., Garvin, A. D. and Cote, M. L. (2008), Total burden and incidence of in situ and invasive cervical carcinoma in Michigan, 1985–2003. Cancer, 113: 2946–2954. doi: 10.1002/cncr.23747

Author Information

  1. 1

    Michigan Cancer Surveillance Program, Michigan Department of Community Health, Lansing, Michigan

  2. 2

    Division of STD Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia

  3. 3

    Cancer Control Section, Michigan Department of Community Health, Lansing, Michigan

  4. 4

    Population Studies and Prevention, Karmanos Cancer Institute and Wayne State University School of Medicine, Detroit, Michigan

  1. §

    Fax: (517) 335-9711.

*Michigan Cancer Surveillance Program, Michigan Department of Community Health, 201 Townsend, PO Box 30691, Lansing, MI 48913

  1. †

    This article is a US Government work and, as such, is in the public domain in the United States of America.

  2. ‡

    The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention.

Publication History

  1. Issue published online: 3 NOV 2008
  2. Article first published online: 3 NOV 2008
  3. Manuscript Accepted: 6 JUN 2008
  4. Manuscript Revised: 2 JUN 2008
  5. Manuscript Received: 14 APR 2008

Funded by

  • Centers for Disease Control
  • National Cancer Institute
  • Michigan Department of Community Health
  • Cooperative Agreement. Grant Number: U50 DP424071-04
  • Centers for Disease Control and Prevention (CDC)

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (192K)

REFERENCES

  • 1
    Munoz N,Bosch FX,de Sanjose S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003; 348: 518–527.
  • 2
    Markowitz LE,Dunne EF,Saraiya M,Lawson HW; Centers for Disease Control and Prevention (CDC); Advisory Committee on Immunization Practices (ACIP). Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2007; 56(RR-2): 1–24.
  • 3
    Zeig-Owens R,Knowlton R,Gershman ST,Howe HL. CINA Highlights of Cancer Incidence and Mortality in the United States and Canada, 2000-2004. Springfield, IL: North American Association of Central Cancer Registries; 2007.
  • 4
    U.S. Cancer Statistics Working Group. United States Cancer Statistics: 2004 Incidence and Mortality. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; 2007.
  • 5
    North American Association of Central Cancer Registries. Working Group on Pre-Invasive Cervical Neoplasia and Population-Based Cancer Registries: Final Subcommittee Report. ([N]AACCR Conference held April 5-6, 1993, Rockville, MD. Adopted by the [N]AACCR Executive Board May 1993 and amended November 1993.)
  • 6
    HofferkampJ,HavenerL, eds. Standards for Cancer Registries. Volume II: Data Standards and Data Dictionary.12th ed. Version 11.2. Springfield, IL: North American Association of Central Cancer Registries; 2007.
  • 7
    Cancer. ACoSCo. Facility Oncology Registry Data Standards: Revised for 2007 (FORDS). Chicago: American College of Surgeons Commission on Cancer; 2002. Updated 2007.
  • 8
    Saraiya M,Goodman MT,Datta D,Chen VW,Wingo PA. Cancer registries and monitoring the impact of prophylactic HPV vaccines: potential role. Cancer. 2008; 113( 10 suppl): 3047–3057.
    Direct Link:
  • 9
    Census Quickfacts. Available at: http://quickfacts.census.gov/qfd/states/26000.hml Accessed October 24, 2007.
  • 10
    Watson M, et al. Using population-based cancer registry data to assess the burden of HPV-associated cancers in the US: Overview of methods. Cancer 2008; 113( 10 suppl): 2841–2854.
    Direct Link:
  • 11
    Cornelison TL,Montz FJ,Bristow RE,Chou B,Bovicelli A,Zeger SL. Decreased incidence of cervical cancer in Medicare-eligible California women. Obstet Gynecol. 2002; 100: 79–86.
  • 12
    Sherman ME,Wang S,Carreon J,Devesa S. Mortality trends for cervical squamous and adenocarcinoma in the United States. Relation to incidence and survival. Cancer. 2005; 103: 1258–1264.
    Direct Link:
  • 13
    Henson RM,Wyatt SW,Lee NC. The National Breast and Cervical Cancer Early Detection Program: a comprehensive public health response to 2 major health issues for women. J Public Health Manag Pract. 1996; 2: 36–47.
  • 14
    Janerich DT,Hadjimichael O,Schwartz PE, et al. The screening histories of women with invasive cervical cancer, Connecticut. Am J Public Health. 1995; 85: 791–794.
  • 15
    Bohm S,Rafferty A,McGee H. Health risk behaviors in the state of Michigan: 2002 Behavioral Risk Factor Survey. Lansing, MI: Michigan Department of Community Health, Bureau of Epidemiology, Epidemiology Services Division; 2003.
  • 16
    Lundberg GD. The 1988 Bethesda System for reporting cervical/vaginal cytological diagnoses. JAMA. 1989; 262: 931–934.
  • 17
    Koss LG. The new Bethesda System for reporting results of smears of the uterine cervix. J Natl Cancer Inst. 1990; 82: 988–991.
View Full Article (HTML) Get PDF (192K)